Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ADI
|
Peter Real
SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 24.95% |
$244,620
$81.54 p/Share
|
May 22
2017 |
ADI
|
Margaret K Seif
SVP, CPO and CLO |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 13.39% |
$244,620
$81.54 p/Share
|
May 22
2017 |
AAPL
|
Johny Srouji
Senior Vice President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 9.37% |
$1,532,000
$153.2 p/Share
|
May 22
2017 |
AAPL
|
Eduardo H Cue
Senior Vice President |
SELL
Open market or private sale
|
Indirect | 45,000 Reduced 90.92% |
$6,920,100
$153.78 p/Share
|
May 22
2017 |
GST
|
Ares Management LLC
Director |
BUY
Open market or private purchase
|
Indirect | 514,227 Added 0.91% |
$617,072
$1.2 p/Share
|
May 22
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 208,031 Added 0.69% |
$8,009,194
$38.5 p/Share
|
May 22
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 86,888 Added 0.61% |
$3,371,254
$38.8 p/Share
|
May 22
2017 |
D
|
Susan N Story
Director |
BUY
Open market or private purchase
|
Direct | 31 Added 0.14% |
$2,471
$79.71 p/Share
|
May 22
2017 |
BKGM
|
Francisco M. Atalig
SVP/Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 400 Reduced 23.88% |
$4,000
$10.0 p/Share
|
May 19
2017 |
CCK
|
David A. Beaver
VP and Corporate Controller |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 29.43% |
$56,050
$56.05 p/Share
|
May 19
2017 |
AAMC
|
Dale Kurland
Director |
SELL
Open market or private sale
|
Direct | 65 Reduced 9.15% |
$4,745
$73.0 p/Share
|
May 19
2017 |
EA
|
Jacob J. Schatz
EVP, Global Affairs and CLO |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 8.82% |
$236,236
$107.38 p/Share
|
May 19
2017 |
NVDA
|
Michael Byron
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 25,507 Reduced 15.68% |
$3,496,755
$137.09 p/Share
|
May 19
2017 |
HON
|
Bradley T Sheares
Director |
SELL
Open market or private sale
|
Direct | 3,430 Reduced 39.29% |
$451,765
$131.71 p/Share
|
May 19
2017 |
SNPS
|
Aart De Geus
EXECUTIVE CHAIR |
SELL
Open market or private sale
|
Indirect | 64,000 Reduced 14.58% |
$4,544,640
$71.01 p/Share
|
May 19
2017 |
SNPS
|
Aart De Geus
EXECUTIVE CHAIR |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 90.85% |
$14,202,000
$71.01 p/Share
|
May 19
2017 |
SNPS
|
Joseph W Logan
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 6.78% |
$355,250
$71.05 p/Share
|
May 19
2017 |
SNPS
|
Chi Foon Chan
Co-CEO |
SELL
Open market or private sale
|
Direct | 3,750 Reduced 1.8% |
$266,100
$70.96 p/Share
|
May 19
2017 |
SNPS
|
John F Runkel Jr
GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 47.5% |
$710,000
$71.0 p/Share
|
May 19
2017 |
SNPS
|
John Schwarz
Director |
SELL
Open market or private sale
|
Direct | 21,496 Reduced 52.66% |
$1,530,515
$71.2 p/Share
|
May 19
2017 |
ABBV
|
Richard A Gonzalez |
SELL
Open market or private sale
|
Direct | 71,235 Reduced 20.36% |
$4,664,468
$65.48 p/Share
|
May 19
2017 |
COP
|
James D Mc Morran
Vice President |
SELL
Open market or private sale
|
Direct | 9,091 Reduced 100.0% |
$431,550
$47.47 p/Share
|
May 19
2017 |
GST
|
Ares Management LLC
Director |
BUY
Open market or private purchase
|
Indirect | 409,404 Added 0.73% |
$474,909
$1.16 p/Share
|
May 19
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 232,105 Added 0.78% |
$8,868,732
$38.21 p/Share
|
May 19
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 199,269 Added 1.4% |
$7,671,856
$38.5 p/Share
|
May 19
2017 |
GST
|
Ares Management LLC
Director |
BUY
Open market or private purchase
|
Indirect | 409,404 Added 0.74% |
$454,438
$1.11 p/Share
|
May 18
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 239,794 Added 0.41% |
$8,927,531
$37.23 p/Share
|
May 18
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 205,999 Added 0.73% |
$7,727,022
$37.51 p/Share
|
May 18
2017 |
MAS
|
Richard A Manoogian
Director |
SELL
Open market or private sale
|
Direct | 61,340 Reduced 8.56% |
$2,268,967
$36.99 p/Share
|
May 18
2017 |
EA
|
Blake J Jorgensen
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.01% |
$1,045,600
$104.56 p/Share
|
May 18
2017 |
AMKR
|
Winston J Churchill
Director |
SELL
Open market or private sale
|
Direct | 13,402 Reduced 31.77% |
$147,422
$11.0 p/Share
|
May 18
2017 |
HD
|
William G. Lennie
Executive Vice President |
SELL
Open market or private sale
|
Direct | 31,239 Reduced 40.29% |
$4,856,727
$155.47 p/Share
|
May 18
2017 |
ABBV
|
William J Chase
EVP, Finance & Administration |
SELL
Open market or private sale
|
Direct | 38,300 Reduced 17.26% |
$2,502,905
$65.35 p/Share
|
May 18
2017 |
NEE
|
James L Robo
Director |
SELL
Open market or private sale
|
Direct | 52,320 Reduced 13.69% |
$7,153,190
$136.72 p/Share
|
May 18
2017 |
PFGC
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 13,700,465 Reduced 99.45% |
$375,529,744
$27.41 p/Share
|
May 18
2017 |
NVDA
|
Persis Drell
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 9.21% |
$325,050
$130.02 p/Share
|
May 18
2017 |
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 9,019 Reduced 0.37% |
$229,984
$25.5 p/Share
|
May 18
2017 |
AMT
|
David E Sharbutt |
SELL
Open market or private sale
|
Direct | 3,653 Reduced 36.18% |
$469,812
$128.61 p/Share
|
May 18
2017 |
CRSP
|
Rodger Novak
President |
SELL
Open market or private sale
|
Direct | 25,923 Reduced 2.09% |
$415,546
$16.03 p/Share
|
May 17
2017 |
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 22,534 Reduced 0.92% |
$574,842
$25.51 p/Share
|
May 17
2017 |
MDC
|
Herbert T Buchwald
Director |
SELL
Open market or private sale
|
Direct | 26,250 Reduced 100.0% |
$896,175
$34.14 p/Share
|
May 17
2017 |
ARE
|
Stephen Richardson
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 6.47% |
$881,325
$117.51 p/Share
|
May 17
2017 |
EA
|
Patrick Soderlund
Chief Design Officer |
SELL
Open market or private sale
|
Direct | 55,163 Reduced 24.73% |
$5,928,368
$107.47 p/Share
|
May 17
2017 |
HD
|
Craig A Menear
Chair |
SELL
Open market or private sale
|
Direct | 90,661 Reduced 37.76% |
$14,214,738
$156.79 p/Share
|
May 17
2017 |
HD
|
Teresa Wynn Roseborough
EVP, Gen. Counsel & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 29,076 Reduced 51.01% |
$4,567,549
$157.09 p/Share
|
May 17
2017 |
HD
|
Mark Holifield
EVP-Supply Chain & Product Dev |
SELL
Open market or private sale
|
Direct | 48,769 Reduced 59.66% |
$7,649,418
$156.85 p/Share
|
May 17
2017 |
HD
|
Matt Carey
EVP |
SELL
Open market or private sale
|
Direct | 14,680 Reduced 22.08% |
$2,304,907
$157.01 p/Share
|
May 17
2017 |
HD
|
Ann Marie Campbell
Senior EVP |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 11.46% |
$1,095,920
$156.56 p/Share
|
May 17
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 580,907 Added 1.96% |
$21,075,305
$36.28 p/Share
|
May 17
2017 |
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 100,071 Added 0.73% |
$3,647,588
$36.45 p/Share
|
May 17
2017 |